422 related articles for article (PubMed ID: 25946126)
1. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
[TBL] [Abstract][Full Text] [Related]
2. Oral Colonisation after the Administration of Drops Containing Lactobacillus reuteri.
Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
Oral Health Prev Dent; 2020 Nov; 18():1017-1023. PubMed ID: 33215493
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial.
Romani Vestman N; Hasslöf P; Keller MK; Granström E; Roos S; Twetman S; Stecksén-Blicks C
Caries Res; 2013; 47(4):338-45. PubMed ID: 23486236
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S
Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984
[TBL] [Abstract][Full Text] [Related]
5. Oral colonization by Lactobacillus reuteri ATCC 55730 after exposure to probiotics.
Caglar E; Topcuoglu N; Cildir SK; Sandalli N; Kulekci G
Int J Paediatr Dent; 2009 Sep; 19(5):377-81. PubMed ID: 19486373
[TBL] [Abstract][Full Text] [Related]
6. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Iniesta M; Herrera D; Montero E; Zurbriggen M; Matos AR; Marín MJ; Sánchez-Beltrán MC; Llama-Palacio A; Sanz M
J Clin Periodontol; 2012 Aug; 39(8):736-44. PubMed ID: 22694350
[TBL] [Abstract][Full Text] [Related]
7. Changes in the diversity and composition of gut microbiota of weaned piglets after oral administration of Lactobacillus or an antibiotic.
Zhang D; Ji H; Liu H; Wang S; Wang J; Wang Y
Appl Microbiol Biotechnol; 2016 Dec; 100(23):10081-10093. PubMed ID: 27757509
[TBL] [Abstract][Full Text] [Related]
8. Influence of dietary supplementation with Lactobacillus reuteri on the oral flora of healthy subjects.
Sinkiewicz G; Cronholm S; Ljunggren L; Dahlén G; Bratthall G
Swed Dent J; 2010; 34(4):197-206. PubMed ID: 21306085
[TBL] [Abstract][Full Text] [Related]
9. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients.
Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
BMC Microbiol; 2021 Oct; 21(1):271. PubMed ID: 34615458
[TBL] [Abstract][Full Text] [Related]
10. 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.
Roos S; Dicksved J; Tarasco V; Locatelli E; Ricceri F; Grandin U; Savino F
PLoS One; 2013; 8(2):e56710. PubMed ID: 23468874
[TBL] [Abstract][Full Text] [Related]
11. Effects of
Martí M; Spreckels JE; Ranasinghe PD; Wejryd E; Marchini G; Sverremark-Ekström E; Jenmalm MC; Abrahamsson T
Cell Rep Med; 2021 Mar; 2(3):100206. PubMed ID: 33763652
[TBL] [Abstract][Full Text] [Related]
12. Presence of Lactobacillus reuteri in saliva coincide with higher salivary IgA in young adults after intake of probiotic lozenges.
Braathen G; Ingildsen V; Twetman S; Ericson D; Jørgensen MR
Benef Microbes; 2017 Feb; 8(1):17-22. PubMed ID: 27873545
[TBL] [Abstract][Full Text] [Related]
13. The Microbiome in Populations with a Low and High Prevalence of Caries.
Johansson I; Witkowska E; Kaveh B; Lif Holgerson P; Tanner AC
J Dent Res; 2016 Jan; 95(1):80-6. PubMed ID: 26442950
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
Mobini R; Tremaroli V; Ståhlman M; Karlsson F; Levin M; Ljungberg M; Sohlin M; Bertéus Forslund H; Perkins R; Bäckhed F; Jansson PA
Diabetes Obes Metab; 2017 Apr; 19(4):579-589. PubMed ID: 28009106
[TBL] [Abstract][Full Text] [Related]
15. Probiotic supplements (Lactobacillus reuteri DSM 17938 and ATCC PTA 5289) do not affect regrowth of mutans streptococci after full-mouth disinfection with chlorhexidine: a randomized controlled multicenter trial.
Keller MK; Hasslöf P; Dahlén G; Stecksén-Blicks C; Twetman S
Caries Res; 2012; 46(2):140-6. PubMed ID: 22472585
[TBL] [Abstract][Full Text] [Related]
16. [Influence of Lactobacillus reuteri SL001 on intestinal microbiota in AD model mice and C57BL/6 mice].
Liu M; Hu R; Guo Y; Sun W; Li J; Fan M; Wang Y; Du H; Tang Z; Chai C
Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1887-1898. PubMed ID: 33164464
[TBL] [Abstract][Full Text] [Related]
17. Early Colonization of Lactobacillus reuteri after Exposure to Probiotics.
Çaglar E; Topcuoglu N; Ozbey H; Sandalli N; Kulekci G
J Clin Pediatr Dent; 2015; 39(4):326-30. PubMed ID: 26161603
[TBL] [Abstract][Full Text] [Related]
18. A probiotic lozenge administered medical device and its effect on salivary mutans streptococci and lactobacilli.
Caglar E; Kuscu OO; Cildir SK; Kuvvetli SS; Sandalli N
Int J Paediatr Dent; 2008 Jan; 18(1):35-9. PubMed ID: 18086024
[TBL] [Abstract][Full Text] [Related]
19. Effects of
Wälivaara DÅ; Sjögren I; Gerasimcik N; Yucel-Lindberg T; Twetman S; Abrahamsson P
Benef Microbes; 2019 Jul; 10(6):653-659. PubMed ID: 31157556
[TBL] [Abstract][Full Text] [Related]
20. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
